JNJ-18054478

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-18054478, covering 2014-06-18 to 2014-06-18. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients. [Phase 2]